Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 8Breast 6Genitourinary 5Tumor-Agnostic 3Other 3Lymphoid 3Thoracic 2Sarcoma 2Head & Neck 2Other hematologic neoplasm 1Gynecologic 1Endocrine 1CNS 1

Conditions

Sarcoma, Ewing 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Osteosarcoma 1

Interventions

Cytarabine 898Cyclophosphamide 893fludarabine 517venetoclax 475fludarabine phosphate 464Azacitidine 451Rituximab 418Methotrexate 414Etoposide 319Filgrastim 299Busulfan 295Dexamethasone 284Vincristine 280Daunorubicin 279Peripheral Blood Stem Cell Transplantation 257Whole-Body Irradiation 240Mycophenolic Acid 231Decitabine 228Granulocyte Colony-Stimulating Factor 225Tacrolimus 219Idarubicin 203Melphalan 201Imatinib Mesylate 195Cyclosporine 182Doxorubicin 176Radiotherapy 169Prednisone 161Mitoxantrone 160Lenalidomide 159Mercaptopurine 154

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Electroacupuncture × Other hematologic neoplasm × Clear all
NCT01492569 2013-06-12

Acupuncture Point Stimulation for Treatment of Chemotherapy Nausea and Vomiting

Stanford University

Phase NA Withdrawn
LymphoidOther hematologic neoplasmSarcoma

Sarcoma, Ewing, Osteosarcoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡